Keywords: strong, early, data, davanat, plus, 5-fu, crc

Strong early data on Davanat plus 5-FU in CRC

Article | 10 March 2008

Print This

The USA's Pro-Pharmaceuticals says that data from all end-stage colorectal cancer patients in a Phase II trial showed that its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in